Cancer Research UK logo.
SearchDonate
  • Search

A trial of chemoradiotherapy with or without pembrolizumab for cervical cancer (KEYNOTE-A18)

Overview

Cancer types:

Cervical cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at pembrolizumab for cervical cancer that has spread into the surrounding tissue (locally advanced) and has a high risk of coming back.

Recruitment start: 21 May 2021

Recruitment end: 18 November 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Susan Lalondrelle

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 21 November 2022

CRUK internal database number: 17441

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.